×

Subscribe Today

Get our free articles delivered directly to your email!

Continue reading

LianBio. (LIAN) NASDAQ

$4.93 - (-)

Market Cap: -

As of 03/08/24 12:00 AM EST. Market closed.

(LIAN)

LianBio. (LIAN)
NASDAQ

$4.93
- (-)

Market Cap: -

As of 03/08/24 12:00 AM EST. Market closed.

Add to Portfolio

lianbio’s mission is to catalyze the development and accelerate availability of paradigm-shifting medicines to patients in china and major asian markets through partnerships that provide access to the best science-driven therapeutic discoveries. lianbio collaborates with world-class partners across a diverse array of therapeutic and geographic areas to build out a pipeline based on disease ... read more

COMPANY PROFILE
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology
URL
Address
.
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology
URL
Address
.
PRICE CHART FOR LIANBIO
1w
1m
3m
6m
YTD
1y
5y
MAX
From: To:
NEWS
INSIDEARBITRAGE ARTICLES
KEY STATS
Open
$0.33
Previous Close
$4.93
Days Range
$4.90 - $4.96
52 week range
- - -
Volume
171,431
Avg. Volume (30 days)
0
Market Cap
-
Dividend Yield
-
P/E
-
Shares Outstanding
108,062,638
Open
$0.33
Previous Close
$4.93
Days Range
$4.90 - $4.96
52 week range
- - -
Volume
171,431
Avg. Volume (30 days)
0
Market Cap
-
Dividend Yield
-
P/E
-
Shares Outstanding
108,062,638
FINANCIAL STATEMENTS FOR LIANBIO
LOADING...

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

INSIDER TRANSACTIONS FOR LIANBIO
OwnerRelationshipDateTransactionCost# SharesValue($)Total SharesForm 4
Gu EhongInterim CFOApr 09, 2024 Option Exercise$0.3217,8895,7240Apr 11, 2024, 04:10 PM
Gu EhongInterim CFOJan 02, 2024 Sale$4.341,7317,51376,762Apr 11, 2024, 04:10 PM
Poukalov KonstantinDirectorFeb 15, 2024 Option Exercise$4.7619,21891,47817,082Feb 20, 2024, 05:27 PM
Poukalov KonstantinDirectorFeb 15, 2024 Option Exercise$2.5236,30091,47636,300Feb 20, 2024, 05:27 PM
PERCEPTIVE ADVISORS LLCDirectorFeb 15, 2024 Option Exercise$4.7638,436182,95517,082Feb 20, 2024, 05:25 PM
PERCEPTIVE ADVISORS LLCDirectorFeb 15, 2024 Option Exercise$2.5272,600182,95236,300Feb 20, 2024, 05:25 PM
Stone Adam LeoInterim CEOFeb 15, 2024 Option Exercise$4.7619,21891,47817,082Feb 20, 2024, 05:23 PM
Stone Adam LeoInterim CEOFeb 15, 2024 Option Exercise$2.5236,30091,47636,300Feb 20, 2024, 05:23 PM
GIANAKAKOS ANASTASIOSDirectorFeb 15, 2024 Option Exercise$4.7619,21891,47853,630Feb 20, 2024, 04:11 PM
GIANAKAKOS ANASTASIOSDirectorFeb 15, 2024 Option Exercise$2.5236,30091,47672,848Feb 20, 2024, 04:11 PM
QIAN JIANGSVP, China General ManagerJan 03, 2023 Sale$1.652,2393,70267,349Jan 05, 2023, 04:29 PM
PERCEPTIVE ADVISORS LLCDirectorAug 18, 2022 Buy$2.40998,2402,395,7763,728,491Aug 22, 2022, 09:17 AM
PERCEPTIVE ADVISORS LLCDirectorMay 26, 2022 Buy$3.1369,000215,9702,730,251May 27, 2022, 10:06 AM
PERCEPTIVE ADVISORS LLCDirectorMay 25, 2022 Buy$2.63120,000315,6002,661,251May 25, 2022, 06:51 PM
PERCEPTIVE ADVISORS LLCDirectorMay 24, 2022 Buy$2.4742,551105,1012,541,251May 25, 2022, 06:51 PM
PERCEPTIVE ADVISORS LLCDirectorMay 23, 2022 Buy$2.498,70021,6632,498,700May 25, 2022, 06:51 PM
Yu DebraSee RemarksMay 04, 2022 Option Exercise$1.711,000,0001,710,0001,000,000May 06, 2022, 04:15 PM
GIANAKAKOS ANASTASIOSDirectorDec 29, 2021 Option Exercise$6.4936,548237,19736,548Jan 03, 2022, 04:20 PM
PERCEPTIVE ADVISORS LLCDirectorNov 03, 2021 Buy$15.982,270,00036,270,20027,858,895Nov 05, 2021, 01:47 PM
PERCEPTIVE ADVISORS LLCDirectorNov 02, 2021 Buy$13.50100,0001,350,0007,253,885Nov 03, 2021, 06:59 PM
PERCEPTIVE ADVISORS LLCDirectorNov 01, 2021 Buy$15.50120,0001,860,0007,153,885Nov 03, 2021, 06:59 PM
Load More Insider Transactions
Buy Sale Option Exercise
OwnerRelationshipDateValue($)
Gu EhongInterim CFO04/09/20245,724
Gu EhongInterim CFO01/02/20247,513
Poukalov KonstantinDirector02/15/202491,478
Poukalov KonstantinDirector02/15/202491,476
PERCEPTIVE ADVISORS LLCDirector02/15/2024182,955
PERCEPTIVE ADVISORS LLCDirector02/15/2024182,952
Stone Adam LeoInterim CEO02/15/202491,478
Stone Adam LeoInterim CEO02/15/202491,476
GIANAKAKOS ANASTASIOSDirector02/15/202491,478
GIANAKAKOS ANASTASIOSDirector02/15/202491,476
QIAN JIANGSVP, China General Manager01/03/20233,702
PERCEPTIVE ADVISORS LLCDirector08/18/20222,395,776
PERCEPTIVE ADVISORS LLCDirector05/26/2022215,970
PERCEPTIVE ADVISORS LLCDirector05/25/2022315,600
PERCEPTIVE ADVISORS LLCDirector05/24/2022105,101
PERCEPTIVE ADVISORS LLCDirector05/23/202221,663
Yu DebraSee Remarks05/04/20221,710,000
GIANAKAKOS ANASTASIOSDirector12/29/2021237,197
PERCEPTIVE ADVISORS LLCDirector11/03/202136,270,200
PERCEPTIVE ADVISORS LLCDirector11/02/20211,350,000
PERCEPTIVE ADVISORS LLCDirector11/01/20211,860,000
Load More Insider Transactions
FUNDS WITH A POSITION IN LIANBIO
Fund# Shares Owned% of Portfolio% ChangeInvesting Style
VIKING GLOBAL INVESTORS LP3,564,1730.06%ExitedGrowth At A Reasonable Price
TYBOURNE CAPITAL MANAGEMENT (HK) LTD3,398,8902.26%ExitedGrowth, Growth At A Reasonable Price
BLACKROCK INC.1,195,7160.00014%ExitedOther
RENAISSANCE TECHNOLOGIES LLC346,0000.00239%ExitedOther
GEODE CAPITAL MANAGEMENT, LLC25,0270.00001%ExitedOther
CHANGE IN SHARES OUTSTANDING FOR LIANBIO
STOCK BUYBACKS FOR LIANBIO
Period of Report
Previous Period
% Change in Shares
10-K/10-Q Filings
Quarter
09/30/2023
06/30/2023
0%
1Q
09/30/2023
03/31/2023
0.01%
2Q
09/30/2023
12/31/2022
-0.89%
3Q
09/30/2023
09/30/2022
-1.09%
4Q
09/30/2023
06/30/2022
-0.70%
5Q
09/30/2023
03/31/2022
-0.10%
6Q
Load More

Period of Report: 09/30/2023

10-K/10-Q Filings: View

Previous Period
% Change in Shares
Quarter
06/30/2023
0%
1Q
03/31/2023
0.01%
2Q
12/31/2022
-0.89%
3Q
09/30/2022
-1.09%
4Q
06/30/2022
-0.70%
5Q
03/31/2022
-0.10%
6Q
Load More
BUYBACK ANNOUNCEMENT(S) FOR LIANBIO
LOADING...